| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Mancini Marianna is a Chief Operating Officer at Viking Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $13.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Chief Operating Officer | Sell | 57,661 | $32.98 | $1,901,405.31 | -3.3% | +5.6% | - | |
| Oct 28, 2025 | VKTX Viking Therapeutics, Inc. | Chief Operating Officer | Sell | 6,185 | $35.00 | $216,491.70 | -1.6% | -9.2% | - | |
| Jul 3, 2025 | VKTX Viking Therapeutics, Inc. | Chief Operating Officer | Sell | 4,266 | $27.77 | $118,472.79 | -1.1% | -2.9% | - | |
| Jan 6, 2025 | VKTX Viking Therapeutics, Inc. | Chief Operating Officer | Sell | 54,215 | $42.75 | $2,317,599.12 | -6.7% | -50.0% | -24.1% | |
| Jul 30, 2024 | VKTX Viking Therapeutics, Inc. | Chief Operating Officer | Sell | 18,026 | $57.13 | $1,029,911.96 | -2.4% | +31.8% | -40.4% | |
| May 1, 2024 | VKTX Viking Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 281,425 | $78.66 | $22,136,473.80 | -10.6% | -26.0% | -62.6% | |
| Apr 17, 2023 | VKTX Viking Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 12,500 | $20.00 | $250,000.00 | -4.2% | -21.1% | +246.2% | |
| Mar 29, 2023 | VKTX Viking Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 237,805 | $15.17 | $3,608,317.00 | -30.2% | -6.9% | +414.8% |